TY - JOUR
T1 - Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma
T2 - Systematic review and meta-analysis
AU - Rainsbury, James W
AU - Ahmed, Waseem
AU - Williams, Hazel K
AU - Roberts, Sally
AU - Paleri, Vinidh
AU - Mehanna, Hisham
N1 - Copyright © 2012 Wiley Periodicals, Inc.
PY - 2013/7
Y1 - 2013/7
N2 - BACKGROUND: Human papillomavirus (HPV) positivity improves prognosis in patients with oropharyngeal squamous cell carcinoma (OPSCC). Combining HPV status with other biomarkers may improve its prognostic power. METHODS: The approach was a literature search for longitudinal studies of biomarkers in OPSCC, with systematic review and meta-analysis. RESULTS: In all, 3130 articles were identified; 32 satisfied the inclusion and exclusion criteria. On meta-analysis, there was a significant overall survival (OS) benefit for patients with HPV positive and p16 positive tumors. There was some evidence of improved OS of OPSCC patients with raised bcl2; amplification of 11q3 and loss of 16q genes; and low c-met, ki67, IMD, PLK, FHIT, nuclear surviving, or nuclear cyclin D1. However, none of these was suitable for meta-analysis. CONCLUSION: Survival from OPSCC is associated with several biomarkers, which constitute potential targets for research into improving the prognostic power of HPV in OPSCC. Larger trials are needed, with standardization of cut-points and adherence to consensus reporting guidelines. © 2012 Wiley Periodicals, Inc. Head Neck, 2012.
AB - BACKGROUND: Human papillomavirus (HPV) positivity improves prognosis in patients with oropharyngeal squamous cell carcinoma (OPSCC). Combining HPV status with other biomarkers may improve its prognostic power. METHODS: The approach was a literature search for longitudinal studies of biomarkers in OPSCC, with systematic review and meta-analysis. RESULTS: In all, 3130 articles were identified; 32 satisfied the inclusion and exclusion criteria. On meta-analysis, there was a significant overall survival (OS) benefit for patients with HPV positive and p16 positive tumors. There was some evidence of improved OS of OPSCC patients with raised bcl2; amplification of 11q3 and loss of 16q genes; and low c-met, ki67, IMD, PLK, FHIT, nuclear surviving, or nuclear cyclin D1. However, none of these was suitable for meta-analysis. CONCLUSION: Survival from OPSCC is associated with several biomarkers, which constitute potential targets for research into improving the prognostic power of HPV in OPSCC. Larger trials are needed, with standardization of cut-points and adherence to consensus reporting guidelines. © 2012 Wiley Periodicals, Inc. Head Neck, 2012.
U2 - 10.1002/hed.22950
DO - 10.1002/hed.22950
M3 - Article
C2 - 22997051
SN - 1097-0347
VL - 35
SP - 1048
EP - 1055
JO - Head & Neck
JF - Head & Neck
IS - 7
ER -